Press release
Hyperuricemia Market Grows with Febuxostat Uptake & Lifestyle Disease Surge in Japan | Arthrosi Therapeutics, Inc, Dr.Reddy's, Urica Therapeutics, Inc, Zydus Lifesciences, Takeda Pharmaceutical Company Limited
Hyperuricemia Market
Hyperuricemia Market Report by DataM Intelligence offers a detailed assessment of the global metabolic and rheumatology landscape, highlighting market size, key players, and critical growth drivers. With expanding uricosuric pipelines, growing guideline emphasis on cardiovascular risk management in gout patients, and broader access to specialty therapies, the report delivers strategic insights for stakeholders from 2025 to 2033.
In 2025, Japan and Asia advanced selective URAT1 inhibitors (e.g., dotinurad) into wider clinical adoption and regulatory launches, while new pharmacoepidemiology studies clarified drug-induced hyperuricemia risk windows both trends that are informing prescribing and reimbursement decisions.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/hyperuricemia-market?ophp
Hyperuricemia Market Competitors Overview:
Arthrosi Therapeutics, Inc, Dr.Reddy's, Urica Therapeutics, Inc, Zydus Lifesciences, Takeda Pharmaceutical Company Limited, Novartis AG, Hikma Pharmaceuticals Plc, Mylan N.V., AstraZeneca Plc, Sun Pharmaceutical Industries Ltd and among others.
Important Industry Updates:
In April 2023, in the HAMANGO-C trial, the efficacy of vitamin C in treating hyperuricemia and gout is examined. In order to ascertain the impact of vitamin C supplementation on blood urate levels in Hmong people with or without gout, researchers at the University of Minnesota in the United States have started a study called "the Hmong Microbiome and Gout, Obesity, Vitamin C (HMANGO-C)".
Methodology and Scope
The Hyperuricemia Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/hyperuricemia-market?ophp
Hyperuricemia Market Segments Overview:
∎By Type
Primary
Secondary
∎By Age Group
Children
Adults
∎By Drug Type
Xanthine Oxidase Inhibitors
Nonsteroidal Anti-Inflammatory Drugs
Corticosteroids
Others
∎ By Route of Administration
Oral
Injectable
∎ By Distribution Channel
Hospital pharmacies
Retail pharmacies
Online pharmacies
Regional Overview for Hyperuricemia Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=hyperuricemia-market
The Report Covers:
➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the Hyperuricemia market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Hyperuricemia market?
Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hyperuricemia Market Grows with Febuxostat Uptake & Lifestyle Disease Surge in Japan | Arthrosi Therapeutics, Inc, Dr.Reddy's, Urica Therapeutics, Inc, Zydus Lifesciences, Takeda Pharmaceutical Company Limited here
News-ID: 4142690 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Autonomous Data Platform Market to Reach USD 14.96 Billion by 2032, Report by Da …
Overview of the Autonomous Data Platform Market
The Autonomous Data Platform (ADP) market is witnessing rapid growth, driven by digital transformation and the increasing need for real-time data analytics. ADPs use Artificial Intelligence (AI) and Machine Learning (ML) to automate data management, enabling businesses to make faster, data-driven decisions while minimizing human intervention. These platforms enhance operational efficiency, reduce errors, and allow enterprises to focus on strategic initiatives. ADPs are increasingly…
Global 6G Technology Market to Reach USD 9.03 Billion by 2032, Report by DataM I …
Overview of the Global 6G Technology Market
The 6G technology market represents the next frontier in wireless communication, promising unprecedented advancements in speed, connectivity, and intelligence. Building upon the foundation laid by 5G, 6G aims to deliver peak data rates exceeding 1 terabit per second, ultra-low latency, and seamless integration of artificial intelligence (AI) and quantum-resistant encryption. These capabilities are set to revolutionize industries such as healthcare, automotive, manufacturing, and entertainment…
Spinal Muscular Atrophy Treatment Market to Reach USD 20.06 Billion by 2033, Rep …
Overview of the Spinal Muscular Atrophy Treatment Market
Spinal Muscular Atrophy (SMA) is a rare genetic disorder characterized by progressive muscle weakness, leading to severe physical disability and, in many cases, early death. The advent of innovative therapies has significantly altered the treatment landscape for SMA, offering hope for improved patient outcomes. Gene therapies, such as onasemnogene abeparvovec (Zolgensma), nusinersen (Spinraza), and risdiplam (Evrysdi), have demonstrated efficacy in increasing survival rates…
United States Prime Editing and CRISPR Market 2025 | Growth Drivers, Key Players …
Market Size and Growth
Prime Editing and CRISPR Market is estimated to grow at a CAGR of 24.1% during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ July 2025 - Prime Medicine announced an additional investment of up to $24 million from the Cystic Fibrosis Foundation to advance gene editing therapy targeting the G542X mutation, a prevalent cystic fibrosis-causing mutation with no current therapies.
✅ July 2025 - CRISPR…
More Releases for Hyperuricemia
Hyperuricemia Drugs Market Size, Share and Growth Report, 2034
" The hyperuricemia drug market is projected to reach a valuation of approximately $7.5 billion in 2024, driven by the rising prevalence of gout and escalating healthcare expenditures. The anticipated market growth for the period from 2025 to 2034 is expected to propel the market value to around $12 billion, reflecting an impressive Compound Annual Growth Rate (CAGR) of 5.4%. "
Exactitude Consultancy., Ltd. released a research report titled "Hyperuricemia Drugs…
What's Driving the Hyperuricemia Drugs Market 2025-2034: Rising Incidence Of Hyp …
What Are the Projections for the Size and Growth Rate of the Hyperuricemia Drugs Market?
The market size of drugs for hyperuricemia has seen robust growth in the past few years. The market is expected to expand from $4.75 billion in 2024 to $5.16 billion in 2025, displaying a compound annual growth rate (CAGR) of 8.5%. The historical growth can be credited to factors such as the escalating cases of gout,…
Hyperuricemia Market Statistical Forecast, Trade Analysis 2024 - 2031
DataM Intelligence has published a new research report on "Hyperuricemia Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/hyperuricemia-market
The…
Hyperuricemia Drugs Market: Insights and Forecast | 2024-2030
Hyperuricemia Drugs Market Overview:
Maximize Market Research a business Analytics company has released a report on the "Hyperuricemia Drugs Market". As per the "Hyperuricemia Drugs report," the total market size value from 2023 and estimated value for 2030 with a CAGR forecasted from 2024 to 2030.
Projected Growth in Revenue:
The Hyperuricemia Drugs Market size was valued at USD 5.08 Billion in 2023 and the total Hyperuricemia Drugs Market revenue is expected to…
Hyperuricemia Market Analysis and Precise Outlook 2020-2030
Hyperuricemia Market Insights, Epidemiology, and Market Forecast-2030: The Hyperuricemia market report provides current treatment practices, emerging drugs, Hyperuricemia market share of the individual therapies, current and forecasted Hyperuricemia market Size from 2017 to 2030 segmented by seven major markets.
The report delivers an in-depth understanding of the Hyperuricemia, historical and forecasted epidemiology as well as the Hyperuricemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom)…
Hyperuricemia-Pipeline Review H2 2018
Hyperuricemia-Pipeline Review, H2 2018
Summary
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Hyperuricemia-Pipeline Review, H2 2018, provides an overview of the Hyperuricemia (Metabolic Disorders) pipeline landscape.
High uric acid level, or hyperuricemia, is an excess of uric acid in blood. Symptoms include joints become swollen, tender and red, fever, chills, fatigue and kidney problems (caused by formation of kidney stones), or problems with urination. Predisposing factors include age, family history and certain…
